A series of benzo[b]thiophen-3-ols were synthesised and investigated as potential human monoamine oxidase (hMAO) inhibitors in vitro as well as ex vivo in rat cortex synaptosomes by means of evaluation of 3,4-dihydroxyphenylacetic acid/dopamine (DOPAC/DA) ratio and lactate dehydrogenase (LDH) activity. Most of these compounds possessed high selectivity for the MAO-B isoform and a discrete antioxidant and chelating potential. Molecular docking studies of all the compounds underscored potential binding site interactions suitable for MAO inhibition activity, and suggested structural requirements to further improve the activity of this scaffold by chemical modification of the aryl substituents. Starting from this heterocyclic nucleus, novel lead compounds for the treatment of neurodegenerative disease could be developed.

Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity / Guglielmi, Paolo; Secci, Daniela; Petzer, Anél; Bagetta, Donatella; Chimenti, Paola; Rotondi, Giulia; Ferrante, Claudio; Recinella, Lucia; Leone, Sheila; Alcaro, Stefano; Zengin, Gokhan; Petzer, Jacobus P; Ortuso, Francesco; Carradori, Simone. - In: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. - ISSN 1475-6366. - 34:1(2019), pp. 1511-1525. [10.1080/14756366.2019.1653864]

Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity

Guglielmi, Paolo
Primo
;
Secci, Daniela
Secondo
;
Chimenti, Paola;ROTONDI, GIULIA;
2019

Abstract

A series of benzo[b]thiophen-3-ols were synthesised and investigated as potential human monoamine oxidase (hMAO) inhibitors in vitro as well as ex vivo in rat cortex synaptosomes by means of evaluation of 3,4-dihydroxyphenylacetic acid/dopamine (DOPAC/DA) ratio and lactate dehydrogenase (LDH) activity. Most of these compounds possessed high selectivity for the MAO-B isoform and a discrete antioxidant and chelating potential. Molecular docking studies of all the compounds underscored potential binding site interactions suitable for MAO inhibition activity, and suggested structural requirements to further improve the activity of this scaffold by chemical modification of the aryl substituents. Starting from this heterocyclic nucleus, novel lead compounds for the treatment of neurodegenerative disease could be developed.
2019
MAO-B inhibitors; Parkinson’s disease; antioxidant activity; benzothiophene; molecular modelling; rat cortex synaptosomes
01 Pubblicazione su rivista::01a Articolo in rivista
Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity / Guglielmi, Paolo; Secci, Daniela; Petzer, Anél; Bagetta, Donatella; Chimenti, Paola; Rotondi, Giulia; Ferrante, Claudio; Recinella, Lucia; Leone, Sheila; Alcaro, Stefano; Zengin, Gokhan; Petzer, Jacobus P; Ortuso, Francesco; Carradori, Simone. - In: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. - ISSN 1475-6366. - 34:1(2019), pp. 1511-1525. [10.1080/14756366.2019.1653864]
File allegati a questo prodotto
File Dimensione Formato  
Guglielmi_Benzo[b]tiophen_2019.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.44 MB
Formato Adobe PDF
2.44 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1307503
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact